Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
ZJYL Jin Medical International
- 0.860
- +0.010+1.19%
Close Dec 20 16:00 ET
- 0.880
- +0.020+2.31%
Post 20:01 ET
134.63MMarket Cap45.26P/E (TTM)
0.890High0.801Low340.84KVolume0.801Open0.850Pre Close287.86KTurnover0.90%Turnover Ratio47.78P/E (Static)156.55MShares16.60052wk High5.12P/B32.53MFloat Cap0.70152wk Low--Dividend TTM37.82MShs Float25.494Historical High--Div YieldTTM10.48%Amplitude0.242Historical Low0.844Avg Price1Lot Size
Jin Medical International Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | |
|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||
| Cash flow from continuing operating activities | 96.53%3.11M | -72.95%1.58M | 133.43%5.84M | 2.5M |
| Net income from continuing operations | 6.34%2.88M | 2.84%2.71M | 19.30%2.63M | --2.21M |
| Operating gains losses | ---6.86K | ---- | 3,741.09%13.37K | --348 |
| Depreciation and amortization | -37.70%225.9K | 4.61%362.6K | 5.06%346.61K | --329.91K |
| Deferred tax | 204.16%89.6K | -5,072.76%-86.02K | 97.87%-1.66K | ---77.92K |
| Change In working capital | 85.97%-200.81K | -148.33%-1.43M | 8,597.76%2.96M | ---34.86K |
| -Change in receivables | -212.71%-376.08K | -89.16%333.66K | 173.60%3.08M | --1.12M |
| -Change in inventory | 408.38%1.56M | -209.98%-504.39K | 133.45%458.61K | ---1.37M |
| -Change in prepaid assets | -266.31%-716.36K | 154.36%430.74K | -4,642.58%-792.44K | ---16.71K |
| -Change in payables and accrued expense | 26.92%-684.07K | -117.80%-936.03K | -233.18%-429.77K | --322.7K |
| -Change in other working capital | 102.68%20.26K | -216.60%-755.37K | 785.46%647.86K | ---94.51K |
| Cash from discontinued investing activities | ||||
| Operating cash flow | 96.53%3.11M | -72.95%1.58M | 133.43%5.84M | --2.5M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -6,293.71%-7.73M | 88.68%-120.9K | 45.49%-1.07M | -1.96M |
| Net PPE purchase and sale | -158.43%-103.8K | 6.33%-40.17K | 69.83%-42.88K | ---142.11K |
| Net investment purchase and sale | -1,613.17%-7.63M | 45.02%-445.17K | -383.72%-809.73K | --285.4K |
| Net other investing changes | ---- | 269.48%364.43K | 89.77%-215.03K | ---2.1M |
| Cash from discontinued investing activities | ||||
| Investing cash flow | -6,293.71%-7.73M | 88.68%-120.9K | 45.49%-1.07M | ---1.96M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | 5,571.18%6.91M | 104.25%121.86K | -734.59%-2.87M | -343.91K |
| Net issuance payments of debt | --4.25M | --0 | -678.54%-2.77M | ---355.32K |
| Net common stock issuance | --8M | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | --336.64K | --0 | --0 | ---- |
| Net other financing activities | -4,761.29%-5.68M | 217.30%121.86K | -1,009.98%-103.88K | --11.42K |
| Cash from discontinued financing activities | ||||
| Financing cash flow | 5,571.18%6.91M | 104.25%121.86K | -734.59%-2.87M | ---343.91K |
| Net cash flow | ||||
| Beginning cash position | 30.51%4.79M | 120.75%3.67M | -14.34%1.66M | --1.94M |
| Current changes in cash | 44.59%2.29M | -16.99%1.58M | 849.08%1.91M | --200.77K |
| Effect of exchange rate changes | 67.50%-149.9K | -546.49%-461.24K | 121.56%103.3K | ---479.21K |
| End cash Position | 44.59%6.93M | 30.51%4.79M | 120.75%3.67M | --1.66M |
| Free cash flow | 94.25%2.99M | -73.44%1.54M | 145.69%5.8M | --2.36M |
| Currency Unit | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- |